Astria Therapeutics, Inc. (ATXS)
12.96
+0.02
(+0.12%)
USD |
NASDAQ |
Dec 10, 16:00
12.83
-0.14
(-1.04%)
After-Hours: 18:07
Astria Therapeutics Total Assets (Quarterly): 271.87M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| BioCryst Pharmaceuticals, Inc. | 446.42M |
| Hologic, Inc. | 9.015B |
| Johnson & Johnson | 192.82B |
| Alnylam Pharmaceuticals, Inc. | 4.852B |
| CorMedix, Inc. | 750.86M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 38.61M |
| Shareholders Equity (Quarterly) | 233.25M |
| Debt to Equity Ratio | 0.0191 |
| Current Ratio | 10.78 |
| Net Debt Paydown Yield | 0.06% |